This is the old version of SRDR. The next, SRDRplus is available! Registration of your SRDRPlus account is free and approval is automatic. Click Here to register an SRDRPlus account.

Advanced Search

Study Preview



Study Title and Description

Desvenlafaxine versus placebo in the treatment of children and adolescents with major depressive disorder



Key Questions Addressed
2 KQ 1b. How do these benefits and harms vary by subpopulation (e.g., patient characteristics, parent/caregiver characteristics, disorder characteristics, history of previous treatment, comorbid condition, exposure to a traumatic life event)?
  • Comments Comments (
    0
    ) |
5 KQ 3a. In adolescents and children, what are the benefits and harms of combination interventions for DDs (MDD, PDD/dysthymic disorders, or DD NOS)?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Desvenlafaxine versus placebo in the treatment of children and adolescents with major depressive disorder
Author S. Atkinson, S. Lubaczewski, S. Ramaker, R. D. England, D. B. Wajsbrot, R. Abbas and R. L. Findling
Country
Year 2018
Numbers

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Study Data for this published project can be accessed from the SRDR Published Projects page, under the Show Downloadable Content section of this project
Design Details
Question... Follow Up Answer Follow-up Answer




Results & Comparisons

No Results found.

Extraction Form: Study Data for this published project can be accessed from the SRDR Published Projects page, under the Show Downloadable Content section of this project
Design Details
Question... Follow Up Answer Follow-up Answer




Results & Comparisons

No Results found.